Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1419554 · BBLG

Bone Biologics Corp

Filing with the SEC — securities delisted SEC-reporting company Burlington, MA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Securities removed from an exchangeA Form 25-NSE filed on Oct 13, 2026 removes a class of the company’s securities from listing (Removed from Nasdaq Stock Market). It can concern shares, warrants, notes or units — check the form for the class.
  • Net loss in 2025Net loss of $3.1M for the year (2024: −$4.1M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$3.1M−$4.1M
Total assets$5.8M$3.9M
Total liabilities$419K$378K
Stockholders’ equity$5.4M$3.5M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Bone Biologics Corp
Formerly: Bone Biologics, Corp.
CIK
0001419554
Tickers
BBLG
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC — securities delisted
State of incorporation
Delaware
Business address
Burlington, Massachusetts
Industry (SIC)
3842 · Orthopedic, prosthetic and surgical appliances and supplies
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 26, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Oct 26, 2026 · filing
  • Delisted by the exchange (Form 25-NSE): Removed from Nasdaq Stock Market
    Form 25-NSE · filed Oct 13, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 16, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 2, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jun 30, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jun 24, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed May 30, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Apr 11, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Feb 26, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Oct 21, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 4, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 14, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Mar 15, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Mar 4, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Feb 21, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jan 30, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jan 11, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 2, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Nov 29, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 29, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 14, 2023 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Jun 16, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed May 19, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 15, 2023 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed May 1, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 30, 2023 · filing